What they were paid
Ultragenyx Pharmaceutical Director Compensation Table · all 4 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $101,000 | $199,982 | $207,559 | $0 | $508,541 |
| FY2024 | $100,750 | $200,010 | $199,374 | — | $500,134 |
| FY2022 | $100,000 | $199,881 | $199,555 | — | $499,436 |
| FY2021 | $98,750 | $199,914 | $200,227 | — | $498,891 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Ultragenyx Pharmaceutical Inc. DEF 14A filed March 27, 2026, accession 0001308179-26-000174, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Ultragenyx Pharmaceutical Inc. filed document, accession 0001308179-26-000174. Every figure is read from that document and cited to the page and table it appears in. Filed March 27, 2026.
Get the Ultragenyx Pharmaceutical Board Governance Report
$508,541 Daniel G. Welch, FY2025 total director compensation
$500
The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.
Data as of March 27, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).
How this board is paid
company policy · FY2025Ultragenyx Pharmaceutical pays directors a $50,000 cash retainer and $400,000 in equity.
Committees
FY2025 · as the proxy prints themCompensation · Nominating/Governance
The rest of the Ultragenyx Pharmaceutical board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Amrit Ray | Independent Director | $472,541 |
| Corsee D. Sanders | Independent Director | $477,541 |
| Deborah Dunsire | Independent Director | $475,041 |
| Emil D. Kakkis | Director | — |
| Matthew K. Fust | Independent Director | $488,541 |
| Michael Narachi | Independent Director | $490,041 |
| Shehnaaz Suliman | Independent Director | $478,291 |
The full Ultragenyx Pharmaceutical compensation record
free company briefThis page is one director within Ultragenyx Pharmaceutical's record. The company brief lists every named executive and director, each linking to their own page.
Peer companies
named in the Ultragenyx Pharmaceutical proxy · each links to its own free briefOrder RARE
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.